Sunwin International Neutraceuticals Achieves FDA Self-Affirmed GRAS Status for Stevia Extracts

Strategic Insights -

Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN) has successfully attained FDA self-affirmed GRAS (Generally Recognized as Safe) status for its OnlySweet stevia extracts. This achievement marks a significant milestone in the company's partnership with WILD Flavors, a leading provider of natural and health-enhancing ingredients to the food and beverage industry. The self-affirmed GRAS status will enable Sunwin and WILD Flavors to commercialize new and innovative food and beverage products containing OnlySweet stevia extracts, providing a valuable opportunity for consumer packaged goods companies and consumers alike.

Key Takeaways:

  • Sunwin International Neutraceuticals (OTCBB: SUWN) has achieved FDA self-affirmed GRAS status for its OnlySweet stevia extracts, a significant milestone in the company's partnership with WILD Flavors.
  • The self-affirmed GRAS status allows Sunwin and WILD Flavors to commercialize new and innovative food and beverage products containing OnlySweet stevia extracts, providing a valuable opportunity for consumer packaged goods companies and consumers.
  • OnlySweet stevia extracts meet or exceed the specifications of 95% steviol glycoside content established by the World Health Organization (WHO) Joint Expert Committee of Food Additives (JECFA).
  • The partnership between Sunwin and WILD Flavors has resulted in exponential volume growth for stevia sales and opportunities through new routes to market.
  • Sunwin's commitment to sustainable production and supply of high-quality stevia extracts has been enhanced through the technological synergies between Sunwin's production knowledge and WILD Flavors' quality management systems and product development techniques.
  • The stock closed yesterday at 25 cents a share, providing an in-depth profile of Sunwin International Neutraceuticals is available at http://www.wallstreetenews.com/view-company-profiles.php?profile=SUWN_072909.
  • Google Inc. (NASDAQ: GOOG) was up 0.6% on 1.9 million shares traded, while Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) surged 51.1% on 12.9 million shares traded.
  • Human Genome Sciences, Inc. (NASDAQ: HGSI) rose 6.4% on 9.4 million shares traded, with HGS aiming to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

Statistics:

  • OnlySweet stevia extracts meet the safety criteria for use as a general-purpose sweetener in a variety of food products.
  • The self-affirmed GRAS status has resulted in exponential volume growth for stevia sales and opportunities through new routes to market.
  • The stock closed yesterday at 25 cents a share, indicating a potential increase in value for Sunwin International Neutraceuticals.
  • Google Inc. (NASDAQ: GOOG) traded 1.9 million shares, while Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) traded 12.9 million shares, demonstrating significant market activity.
  • Human Genome Sciences, Inc. (NASDAQ: HGSI) traded 9.4 million shares, indicating a high level of investor interest in the company's innovative drugs.

Sources:

  • Stock Market Alerts LLC
  • Marketwire
  • Wall Street News Alert
  • SmarTrend Alert (Comtex News Network, Inc.)
  • Sunwin International Neutraceuticals, Inc.
  • WILD Flavors
  • World Health Organization (WHO) Joint Expert Committee of Food Additives (JECFA)
  • Securities Act of 1933, as amended
  • Securities Exchange Act of 1934, as amended